X
ASH: Lilly builds case for its BTK drug LOXO-305 in lymphoma
https://pharmaphorum.com/news/ash-lilly-builds-case-for-its-btk-drug-loxo-305-in-lymphoma/
American Society of Haematology
As rituximab biosimilars close in, Roche showcases Gazyva superiority
Roche faces competition against its blockbuster haematology drug